Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT◆ | 53,250 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | ABOS | Acumen Pharmaceuticals,… | AGRANT | 35,500 | — | — | +277.3% | Open the original filing on SEC.gov |
| Jun 30, 2025 | KANT | Kineta, Inc./de | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | KANT | Kineta, Inc./de | DTOISS | 13,794 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | KANT | Kineta, Inc./de | AGRANT | 6,000 | — | — | +77.0% | Open the original filing on SEC.gov |
| Jun 23, 2025 | KANT | Kineta, Inc./de | FTAX | 4,706 | $0.26 | $1.2K | -37.6% | Open the original filing on SEC.gov |
| Jun 23, 2025 | KANT | Kineta, Inc./de | MEXER | 12,500 | $0.611 | $7.6K | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | LENZ | LENZ Therapeutics, Inc. | AGRANT◆ | 13,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | CLYM | Climb Bio, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | ABOS | Acumen Pharmaceuticals,… | AGRANT◆ | 19,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 4, 2025 | ABOS | Acumen Pharmaceuticals,… | AGRANT | 12,800 | — | — | — | Open the original filing on SEC.gov |